Send an email
Someone you know may be interested in learning more about Xultophy® 100/3.6. Simply complete all fields below and then submit to share this information.
Please correct the highlighted field(s) below before continuing.
This is the message that will be sent to your recipient:
I thought you may be interested in learning more about Xultophy® 100/3.6 (insulin degludec and liraglutide injection) 100 units/mL and 3.6 mg/mL, a treatment option for adults with type 2 diabetes.
You can find out more about Xultophy® 100/3.6 at Xultophy10036.com. You’ll also find information about starting your medication and staying on track. Plus, you’ll find out how you may be able to save on your prescription and see what support is available to you from Novo Nordisk.
Email addresses are used for this mailing request only and are not saved by Xultophy10036.com or Novo Nordisk for any other purposes.
Xultophy® 100/3.6 is an injectable prescription medicine that contains 2 diabetes medicines, insulin degludec, 100 units/mL, and liraglutide, 3.6 mg/mL. Xultophy® 100/3.6 should be used along with diet and exercise to lower blood sugar (glucose) in adults with type 2 diabetes mellitus when blood sugar levels are not well controlled on: 1) basal insulin (less than 50 units daily) or 2) liraglutide (less than or equal to 1.8 mg daily).
What is the most important information I should know about Xultophy® 100/3.6?
Xultophy® 100/3.6 may cause serious side effects, including:
Who should not use Xultophy® 100/3.6? Do not use Xultophy® 100/3.6 if:
What should I tell my health care provider before using Xultophy® 100/3.6?
Tell your health care provider about all your medical conditions, including if you:
Tell your health care provider about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements. Before using Xultophy® 100/3.6, talk to your health care provider about low blood sugar and how to manage it.
How should I use Xultophy® 100/3.6?
Your dose of Xultophy® 100/3.6 may need to change because of change in level of physical activity or exercise, weight gain or loss, increased stress, illness, change in diet, or other medicines you take.
What should I avoid while taking Xultophy® 100/3.6?
What are the possible side effects of Xultophy® 100/3.6?
Xultophy® 100/3.6 may cause serious side effects that can be life-threatening, including:
The most common side effects of Xultophy® 100/3.6 may include stuffy or runny nose, sore throat, upper respiratory tract infection, increased blood levels of lipase, nausea, diarrhea, and headache.
Please see full Prescribing Information and Medication Guide for Xultophy® 100/3.6.
Xultophy® 100/3.6 is a prescription medication.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.
If you need assistance with prescription costs, help may be available. Visit pparx.org or call 1-888-4PPA-NOW.
Xultophy® 100/3.6 is a registered trademark of Novo Nordisk A/S.
Novo Nordisk is a registered trademark of Novo Nordisk A/S.
© 2018 Novo Nordisk All rights reserved. US18XUM00062 October 2018
If you would like to share this site with someone else, click here.